HSBC Adjusts Price Target on Bristol-Myers Squibb to $45 From $50
MT NewswiresMay 1 23:05
Deutsche Bank Adjusts Price Target on Bristol-Myers Squibb to $53 From $55, Keeps Hold Rating
MT NewswiresApr 29 18:45
Bank of Montreal, Canada: Maintaining the Bristol-Myers Squibb (BMY.US) rating, adjusted from a consistent market rating to a consistent market rating, and the target price was adjusted from $55.00 to $48.00.
Zhitong FinanceApr 27 02:10
Bristol-Myers Squibb Analyst Ratings
BenzingaApr 26 21:31
BMO Capital Adjusts Price Target on Bristol-Myers Squibb Company to $48 From $55
MT NewswiresApr 26 19:17
Analysts Offer Insights on Healthcare Companies: Universal Health (UHS), Laboratory (LH) and Bristol-Myers Squibb (BMY)
TipRanksApr 26 17:25
Bristol-Myers Squibb: Hold Rating Amid Mixed Performance and Future Revenue Concerns
TipRanksApr 26 17:19
Barclays Sticks to Their Hold Rating for Bristol-Myers Squibb (BMY)
TipRanksApr 26 16:47
Cantor Fitzgerald Adjusts Price Target on Bristol-Myers Squibb to $45 From $52, Maintains Neutral Rating
MT NewswiresApr 25 23:52
Bristol-Myers Squibb: A Hold Rating Amid Mixed Financial Outlook and Upcoming Strategic Updates
TipRanksApr 25 17:35
Bristol-Myers Squibb Analyst Ratings
BenzingaApr 18 23:03
Wells Fargo Maintains Equal-Weight on Bristol-Myers Squibb, Raises Price Target to $52
BenzingaApr 18 23:04
Analysts' Opinions Are Mixed on These Healthcare Stocks: Accolade (ACCD), Ultragenyx Pharmaceutical (RARE) and Bristol-Myers Squibb (BMY)
TipRanksApr 18 18:10
Jefferies Cuts Bristol-Myers Squibb's Price Target to $56 From $58
MT NewswiresApr 12 19:37
Analysts Have Conflicting Sentiments on These Healthcare Companies: Bristol-Myers Squibb (BMY) and Roche Holding AG (OtherRHHVF)
TipRanksApr 12 18:00
Bristol-Myers Squibb: A Buy Rating on Undervaluation and Promising Product Portfolio
TipRanksApr 12 17:25
Hold Rating on Bristol-Myers Squibb Amid Promising Yet Incomplete KarXT Schizophrenia Trial Data
TipRanksApr 10 14:18
Morgan Stanley Trims Price Target on Bristol-Myers Squibb to $40 From $41, Keeps Underweight Rating
MT NewswiresApr 9 20:05
Bristol-Myers Squibb's Hold Rating: Balancing KarXT's Efficacy and Safety With Financial Uncertainties
TipRanksApr 8 17:47
Wells Fargo Sticks to Its Hold Rating for Bristol-Myers Squibb (BMY)
TipRanksApr 3 17:16
No Data
No Data